Copyright Reports & Markets. All rights reserved.

Global Drug-Eluting Bioabsorbable Stents Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Drug-Eluting Bioabsorbable Stents Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Drug-Eluting Bioabsorbable Stents Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Type
    • 1.4.2 Serolimus and Paclitaxel Drug-Eluting Stents
    • 1.4.3 Sirolimus Drug Eluting Stents
  • 1.5 Market by Application
    • 1.5.1 Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Application
    • 1.5.2 Coronary Artery Diseases
    • 1.5.3 Peripheral Artery Diseases
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Drug-Eluting Bioabsorbable Stents Market Size, Estimates and Forecasts
    • 2.1.1 Global Drug-Eluting Bioabsorbable Stents Revenue 2015-2026
    • 2.1.2 Global Drug-Eluting Bioabsorbable Stents Sales 2015-2026
  • 2.2 Global Drug-Eluting Bioabsorbable Stents, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Drug-Eluting Bioabsorbable Stents Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Drug-Eluting Bioabsorbable Stents Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Drug-Eluting Bioabsorbable Stents Competitor Landscape by Players

  • 3.1 Drug-Eluting Bioabsorbable Stents Sales by Manufacturers
    • 3.1.1 Drug-Eluting Bioabsorbable Stents Sales by Manufacturers (2015-2020)
    • 3.1.2 Drug-Eluting Bioabsorbable Stents Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Drug-Eluting Bioabsorbable Stents Revenue by Manufacturers
    • 3.2.1 Drug-Eluting Bioabsorbable Stents Revenue by Manufacturers (2015-2020)
    • 3.2.2 Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Drug-Eluting Bioabsorbable Stents Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Drug-Eluting Bioabsorbable Stents Revenue in 2019
    • 3.2.5 Global Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Drug-Eluting Bioabsorbable Stents Price by Manufacturers
  • 3.4 Drug-Eluting Bioabsorbable Stents Manufacturing Base Distribution, Product Types
    • 3.4.1 Drug-Eluting Bioabsorbable Stents Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Drug-Eluting Bioabsorbable Stents Product Type
    • 3.4.3 Date of International Manufacturers Enter into Drug-Eluting Bioabsorbable Stents Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Type (2015-2020)
    • 4.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020)
    • 4.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2015-2020)
    • 4.1.3 Drug-Eluting Bioabsorbable Stents Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Type (2021-2026)
    • 4.2.3 Drug-Eluting Bioabsorbable Stents Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Drug-Eluting Bioabsorbable Stents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Application (2015-2020)
    • 5.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020)
    • 5.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2015-2020)
    • 5.1.3 Drug-Eluting Bioabsorbable Stents Price by Application (2015-2020)
  • 5.2 Drug-Eluting Bioabsorbable Stents Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Drug-Eluting Bioabsorbable Stents Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Drug-Eluting Bioabsorbable Stents by Country
    • 6.1.1 North America Drug-Eluting Bioabsorbable Stents Sales by Country
    • 6.1.2 North America Drug-Eluting Bioabsorbable Stents Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type
  • 6.3 North America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Drug-Eluting Bioabsorbable Stents by Country
    • 7.1.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Country
    • 7.1.2 Europe Drug-Eluting Bioabsorbable Stents Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type
  • 7.3 Europe Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Drug-Eluting Bioabsorbable Stents by Region
    • 8.1.1 Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region
    • 8.1.2 Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type
  • 8.3 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Drug-Eluting Bioabsorbable Stents by Country
    • 9.1.1 Latin America Drug-Eluting Bioabsorbable Stents Sales by Country
    • 9.1.2 Latin America Drug-Eluting Bioabsorbable Stents Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type
  • 9.3 Central & South America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents by Country
    • 10.1.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Country
    • 10.1.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type
  • 10.3 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Medtronic
    • 11.1.1 Medtronic Corporation Information
    • 11.1.2 Medtronic Description and Business Overview
    • 11.1.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Products Offered
    • 11.1.5 Medtronic Related Developments
  • 11.2 B.Braun Melsungen
    • 11.2.1 B.Braun Melsungen Corporation Information
    • 11.2.2 B.Braun Melsungen Description and Business Overview
    • 11.2.3 B.Braun Melsungen Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Products Offered
    • 11.2.5 B.Braun Melsungen Related Developments
  • 11.3 Abbott Laboratories
    • 11.3.1 Abbott Laboratories Corporation Information
    • 11.3.2 Abbott Laboratories Description and Business Overview
    • 11.3.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Products Offered
    • 11.3.5 Abbott Laboratories Related Developments
  • 11.4 Boston Scientific Corporation
    • 11.4.1 Boston Scientific Corporation Corporation Information
    • 11.4.2 Boston Scientific Corporation Description and Business Overview
    • 11.4.3 Boston Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Products Offered
    • 11.4.5 Boston Scientific Corporation Related Developments
  • 11.5 Biosensors International
    • 11.5.1 Biosensors International Corporation Information
    • 11.5.2 Biosensors International Description and Business Overview
    • 11.5.3 Biosensors International Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Biosensors International Drug-Eluting Bioabsorbable Stents Products Offered
    • 11.5.5 Biosensors International Related Developments
  • 11.6 Terumo Corporation.
    • 11.6.1 Terumo Corporation. Corporation Information
    • 11.6.2 Terumo Corporation. Description and Business Overview
    • 11.6.3 Terumo Corporation. Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Products Offered
    • 11.6.5 Terumo Corporation. Related Developments
  • 11.7 MicroPort Scientific Corporation
    • 11.7.1 MicroPort Scientific Corporation Corporation Information
    • 11.7.2 MicroPort Scientific Corporation Description and Business Overview
    • 11.7.3 MicroPort Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Products Offered
    • 11.7.5 MicroPort Scientific Corporation Related Developments
  • 11.8 Alvimedica
    • 11.8.1 Alvimedica Corporation Information
    • 11.8.2 Alvimedica Description and Business Overview
    • 11.8.3 Alvimedica Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Alvimedica Drug-Eluting Bioabsorbable Stents Products Offered
    • 11.8.5 Alvimedica Related Developments
  • 11.9 Biotronik
    • 11.9.1 Biotronik Corporation Information
    • 11.9.2 Biotronik Description and Business Overview
    • 11.9.3 Biotronik Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Biotronik Drug-Eluting Bioabsorbable Stents Products Offered
    • 11.9.5 Biotronik Related Developments
  • 11.10 Elixir Medical Corporation
    • 11.10.1 Elixir Medical Corporation Corporation Information
    • 11.10.2 Elixir Medical Corporation Description and Business Overview
    • 11.10.3 Elixir Medical Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Products Offered
    • 11.10.5 Elixir Medical Corporation Related Developments
  • 11.1 Medtronic
    • 11.1.1 Medtronic Corporation Information
    • 11.1.2 Medtronic Description and Business Overview
    • 11.1.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Products Offered
    • 11.1.5 Medtronic Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Drug-Eluting Bioabsorbable Stents Market Estimates and Projections by Region
    • 12.1.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Regions 2021-2026
  • 12.2 North America Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026)
    • 12.2.1 North America: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026)
    • 12.2.2 North America: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026)
    • 12.2.3 North America: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026)
    • 12.3.2 Europe: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Drug-Eluting Bioabsorbable Stents Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Drug-Eluting Bioabsorbable Stents Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Drug-Eluting Bioabsorbable Stents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug-Eluting Bioabsorbable Stents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Drug-Eluting Bioabsorbable Stents market is segmented into
    Serolimus and Paclitaxel Drug-Eluting Stents
    Sirolimus Drug Eluting Stents

    Segment by Application, the Drug-Eluting Bioabsorbable Stents market is segmented into
    Coronary Artery Diseases
    Peripheral Artery Diseases

    Regional and Country-level Analysis
    The Drug-Eluting Bioabsorbable Stents market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Drug-Eluting Bioabsorbable Stents market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Drug-Eluting Bioabsorbable Stents Market Share Analysis
    Drug-Eluting Bioabsorbable Stents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Drug-Eluting Bioabsorbable Stents business, the date to enter into the Drug-Eluting Bioabsorbable Stents market, Drug-Eluting Bioabsorbable Stents product introduction, recent developments, etc.

    The major vendors covered:
    Medtronic
    B.Braun Melsungen
    Abbott Laboratories
    Boston Scientific Corporation
    Biosensors International
    Terumo Corporation.
    MicroPort Scientific Corporation
    Alvimedica
    Biotronik
    Elixir Medical Corporation
    Innovative Health Technologies

    Buy now